MAFTIVIMAB

UNII: KOP95331M4
Preferred Substance Name: MAFTIVIMAB

2135632-36-7
IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN) (HUMAN MONOCLONAL REGN3479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3479 .KAPPA.-CHAIN, DIMER
INMAZEB COMPONENT MAFTIVIMAB-EBGN
MAFTIVIMAB [INN]
MAFTIVIMAB [USAN]
MAFTIVIMAB [WHO-DD]
MAFTIVIMAB-EBGN
REGN3479
REGN-3479
REGN-EB3 COMPONENT MAFTIVIMAB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

MAFTIVIMAB

Synonyms and Mappings

Resources

Note